1. Home
  2. ABEO vs OM Comparison

ABEO vs OM Comparison

Compare ABEO & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • OM
  • Stock Information
  • Founded
  • ABEO 1974
  • OM 2003
  • Country
  • ABEO United States
  • OM United States
  • Employees
  • ABEO N/A
  • OM N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ABEO Health Care
  • OM Health Care
  • Exchange
  • ABEO Nasdaq
  • OM Nasdaq
  • Market Cap
  • ABEO 256.9M
  • OM 305.5M
  • IPO Year
  • ABEO 1980
  • OM 2020
  • Fundamental
  • Price
  • ABEO $5.93
  • OM $19.42
  • Analyst Decision
  • ABEO Strong Buy
  • OM Buy
  • Analyst Count
  • ABEO 6
  • OM 2
  • Target Price
  • ABEO $18.00
  • OM $33.00
  • AVG Volume (30 Days)
  • ABEO 870.0K
  • OM 288.3K
  • Earning Date
  • ABEO 08-11-2025
  • OM 08-06-2025
  • Dividend Yield
  • ABEO N/A
  • OM N/A
  • EPS Growth
  • ABEO N/A
  • OM N/A
  • EPS
  • ABEO N/A
  • OM N/A
  • Revenue
  • ABEO N/A
  • OM $115,273,000.00
  • Revenue This Year
  • ABEO N/A
  • OM $10.80
  • Revenue Next Year
  • ABEO $323.51
  • OM $11.99
  • P/E Ratio
  • ABEO N/A
  • OM N/A
  • Revenue Growth
  • ABEO N/A
  • OM N/A
  • 52 Week Low
  • ABEO $3.93
  • OM $5.85
  • 52 Week High
  • ABEO $7.32
  • OM $72.60
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 45.53
  • OM 57.31
  • Support Level
  • ABEO $6.10
  • OM $18.62
  • Resistance Level
  • ABEO $6.24
  • OM $20.80
  • Average True Range (ATR)
  • ABEO 0.29
  • OM 1.39
  • MACD
  • ABEO -0.09
  • OM -0.30
  • Stochastic Oscillator
  • ABEO 4.26
  • OM 53.62

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About OM Outset Medical Inc.

Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

Share on Social Networks: